Cargando…

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets

Heart failure (HF) and chronic kidney disease (CKD) co-exist, and it is estimated that about 50% of HF patients suffer from CKD. Although studies have been performed on the association between CKD and HF with reduced ejection fraction (HFrEF), less is known about the link between CKD and heart failu...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Wouw, Jens, Broekhuizen, Michelle, Sorop, Oana, Joles, Jaap A., Verhaar, Marianne C., Duncker, Dirk J., Danser, A. H. Jan, Merkus, Daphne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737277/ https://www.ncbi.nlm.nih.gov/pubmed/31551803 http://dx.doi.org/10.3389/fphys.2019.01108

Ejemplares similares

Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors
por: van de Wouw, Jens, et al.
Publicado: (2021)

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction
por: Brandt, Maarten M., et al.
Publicado: (2019)

Perturbations in myocardial perfusion and oxygen balance in swine with multiple risk factors: a novel model of ischemia and no obstructive coronary artery disease
por: van de Wouw, Jens, et al.
Publicado: (2020)

Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction
por: Nguyen, Isabel T. N., et al.
Publicado: (2020)

Mechanobiology of Microvascular Function and Structure in Health and Disease: Focus on the Coronary Circulation
por: Brandt, Maarten M., et al.
Publicado: (2021)

Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement
por: Zhou, Zhichao, et al.
Publicado: (2017)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Krebber, Merle M., et al.
Publicado: (2020)

Experimental animal models of coronary microvascular dysfunction
por: Sorop, Oana, et al.
Publicado: (2020)

Increased index of microcirculatory resistance in older patients with heart failure with preserved ejection fraction
por: Xu, Zhuo, et al.
Publicado: (2018)

Sex differences in pulmonary vascular control: focus on the nitric oxide pathway
por: de Wijs‐Meijler, Daphne P. M., et al.
Publicado: (2017)

Impaired pulmonary vasomotor control in exercising swine with multiple comorbidities
por: van de Wouw, Jens, et al.
Publicado: (2021)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening
por: Sorop, Oana, et al.
Publicado: (2018)

Cardiovascular Function of Modern Pigs Does not Comply with Allometric Scaling Laws
por: van Essen, Gerard J., et al.
Publicado: (2018)

The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Broekhuizen, Michelle, et al.
Publicado: (2021)

Changes in the nitric oxide pathway of the pulmonary vasculature after exposure to hypoxia in swine model of neonatal pulmonary vascular disease
por: de Wijs‐Meijler, Daphne P. M., et al.
Publicado: (2018)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
por: Ovchinnikov, Artem, et al.
Publicado: (2022)

A direct comparison of natural and acoustic-radiation-force-induced cardiac mechanical waves
por: Keijzer, Lana B. H., et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Albumin is an interface between blood plasma and cell membrane, and not just a sponge
por: van de Wouw, Jens, et al.
Publicado: (2021)

Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction
por: van den Dorpel, Mark M. P., et al.
Publicado: (2017)

Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction
por: Bekfani, Tarek, et al.
Publicado: (2021)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction
por: Gaziano, Liam, et al.
Publicado: (2021)

Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction
por: Duncker, Dirk J., et al.
Publicado: (2008)

The microtubule signature in cardiac disease: etiology, disease stage, and age dependency
por: Algül, Sıla, et al.
Publicado: (2023)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Patient‐reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence
por: Huang, Weiting, et al.
Publicado: (2020)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
por: Almahmoud, Mohamed Faher, et al.
Publicado: (2018)

Diastolic index as a short-term prognostic factor in heart failure with preserved ejection fraction
por: Hoshida, Shiro, et al.
Publicado: (2020)

Distinctive prognostic factor of heart failure with preserved ejection fraction stratified with admission blood pressure
por: Nakagawa, Akito, et al.
Publicado: (2021)

Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Heart Failure with Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults
por: Zhao, Li, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis
por: Yu, Xixi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a79udmjgl8mgrs7m372u31q90u